Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Interview with Kevin Hrusovsky part 2: next generation seque...

In the second part of this three-part interview, Kevin Hrusovsky discusses next generation sequencing. In part one of this three-part interview, Kevin Hrusovsky highlighted some exciting recent advances in the understanding of molecular...

Articles

Patients: the least utilised resource in healthcare

We interview Lucien Engelen of the Radboud University Nijmegen on the role of patients in healthcare and what the future of healthcare looks like. An automated external defibrillator (AED) can save lives by allowing the heart to re-establish an effective rhythm. But how to locate...

Articles

Driving down the cost of drug discovery

David Leahy shares his thoughts on driving down drug discovery costs and how this will, in time, allow for better development of personalised medicine. While the pharma industry may believe drug discovery has been fully optimized, David Leahy disagrees. As the...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.